As antimicrobial resistance (AMR) intensifies globally, vaccines and antimicrobial resistance are now closely linked in public health strategies. Vaccines can reduce infections that often require antibiotics, thereby lowering unnecessary antimicrobial use and slowing the spread of resistant strains. Pneumococcal, typhoid, and influenza vaccines have already demonstrated indirect impacts on resistance trends. New vaccine targets for resistant pathogens like Klebsiella, Pseudomonas, and MRSA are under investigation. Incorporating vaccines into AMR mitigation policies could reduce dependence on antibiotics across healthcare and agricultural sectors. Integrating surveillance data from both fields is enhancing policy design and research priorities. Vaccines and antimicrobial resistance intersect as part of a holistic response to preserving drug efficacy and safeguarding future generations.
Submit your abstract Today
